Deversify has successfully completed a rights issue raising proceeds of SEK 11,2 million

Press May 12 2021


Deversify AB has successfully completed a rights issue raising proceeds of SEK 11,2 million. The rights issue has primarily been subscribed for by new Swedish investors from all over the country. Net cash from the rights issue will be used for the continual building and strengthening of the organisation and to support the company’s commercial strategy.

”This rights issue is our largest by far and allows us to step into the next phase of business development and enterprise-building”, says Anders Murman, CEO. He continues: ”With our device, Acetrack, you can measure your rate of fat burning in real time. We are now focusing on accelerating the expansion of Acetrack in Europe and launching our updated, next generation, software. We will also be launching new projects on microsensors and new research on health data – everything to improve the understanding of individual metabolism”.

Read more

DEVERSIFY and RLVNT sign international distribution agreement for Acetrack

Press Sep 1 2021

Deversify AB and RLVNT Distribution AB have signed an agreement for distribution in eight European countries for Acetrack, Deversify’s revolutionising solution for non-invasive measurements of metabolic health. With Acetrack, users can easily track…

Read more

Deversify enters development agreement on new microsensors with KTH spin-off, GattyInstruments

Press Mar 16 2021

Deversify AB announced today that they have signed a hardware research and development agreement with GattyInstruments AB – a start-up from the Royal Institute of Technology (KTH) with business focused on nano and…

Read more